Cbl-b is a negative regulator of receptor clustering and raft aggregation in T cells

被引:177
|
作者
Krawczyk, C
Bachmaier, K
Sasaki, T
Jones, RG
Snapper, SB
Bouchard, D
Kozieradzki, I
Ohashi, PS
Alt, FW
Penninger, JM
机构
[1] Amgen Inst, Toronto, ON M5G 2C1, Canada
[2] Univ Toronto, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2M9, Canada
[3] Univ Toronto, Ontario Canc Inst, Dept Immunol, Toronto, ON M5G 2M9, Canada
[4] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA
基金
英国医学研究理事会;
关键词
D O I
10.1016/S1074-7613(00)00046-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Stimulation of T cells via the antigen and costimulatory receptors leads to the organization of a supramolecular activation cluster called the immune synapse. We report that loss of the molecular adaptor Cbl-b in T cells frees antigen receptor-triggered receptor clustering, lipid raft aggregation, and sustained tyrosine phosphorylation from the requirement for CD28 costimulation. Introduction of the cbl-b mutation into a vav1(-/-) background relieved the functional defects of vav1(-/-) T cells and caused spontaneous autoimmunity. Wiscott Aldrich Syndrome protein (WASP) was found to be essential for deregulated proliferation and membrane receptor reorganization of cbl-b mutant T cells. Antigen receptor-triggered Ca2+ mobilization, cytokine production, and receptor clustering can be genetically uncoupled in cbl-b mutant T cells. Thus, Cbl-b functions as a negative regulator of receptor clustering and raft aggregation in T cells.
引用
收藏
页码:463 / 473
页数:11
相关论文
共 50 条
  • [1] Cbl-b is a negative regulator of pi3-k and map kinases in T cells.
    Zhang, J
    Finnegan, A
    Glant, TT
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S650 - S650
  • [2] CBL-B is a negative regulator of transformation by BCR/ABL.
    Sattler, M
    Pride, YB
    Gramlich, JL
    Quinnan, LR
    Salgia, R
    Lipkowitz, S
    Griffin, JD
    BLOOD, 2002, 100 (11) : 583A - 583A
  • [3] Cbl-b is a negative regulator of inflammatory cytokines produced by IgE-activated mast cells
    Gustin, Sonja E.
    Thien, Christine B. F.
    Langdon, Wallace Y.
    JOURNAL OF IMMUNOLOGY, 2006, 177 (09): : 5980 - 5989
  • [4] Cbl-b is a negative regulator of FcεRI-mediated mast cell activation:: Down-regulation of Gab2 by Cbl-b
    Qu, XJ
    Sada, K
    Yamamura, H
    FASEB JOURNAL, 2004, 18 (05): : A791 - A791
  • [5] Cbl and Cbl-b in T-cell regulation
    Liu, YC
    Gu, H
    TRENDS IN IMMUNOLOGY, 2002, 23 (03) : 140 - 143
  • [6] Cbl-b Is Upregulated and Plays a Negative Role in Activated Human NK Cells
    Lu, Ting
    Chen, Li
    Mansour, Anthony G.
    Yu, Melissa J.
    Brooks, Noah
    Teng, Kun-Yu
    Li, Zhenlong
    Zhang, Jianying
    Barr, Tasha
    Yu, Jianhua
    Caligiuri, Michael A.
    JOURNAL OF IMMUNOLOGY, 2021, 206 (04): : 677 - 685
  • [7] Ubiquitin ligase Cbl-b acts as a negative regulator in discoidin domain receptor 2 signaling via modulation of its stability
    Yu, Jiangtian
    Zhao, Hu
    Zhang, Yan
    Liu, Yun-Cai
    Yao, Libo
    Li, Xia
    Su, Jin
    FEBS LETTERS, 2014, 588 (09) : 1509 - 1514
  • [8] Activation of T Cells: Releasing the Brakes by Proteolytic Elimination of Cbl-b
    Schmitz, M. Lienhard
    SCIENCE SIGNALING, 2009, 2 (76)
  • [9] Cbl-b in T-cell activation
    Magdalena Paolino
    Josef M. Penninger
    Seminars in Immunopathology, 2010, 32 : 137 - 148
  • [10] Cbl-b in T-cell activation
    Paolino, Magdalena
    Penninger, Josef M.
    SEMINARS IN IMMUNOPATHOLOGY, 2010, 32 (02) : 137 - 148